Furthermore, our findings imply that enhancing the autophagy pathway specifically in myeloid cells or topical suppression of IL-1β dysregulation, possibly using saccharin, might serve as a safe and potential therapeutic strategy for alleviating neutrophilic inflammation and improving treatment outcomes in patients with psoriasis. Here, IL1B is linked to psoriasis.